|
Manchado Perero S, Rodriguez Lorente A, Garcia-Perez A, Isidro Garcia G, Forcen-Munoz LA, Ovejero Garcia S, Saez Povedano R, Gonzalez-Galdamez AL, Mata Iturralde L, Ramirez Bonilla M, Fuentes-Perez P, Ovejas-Catalan C, Suarez-Pinilla P, Fernandez Abascal B, Omana Colmenares M, Campos-Navarro MP, Baca-Garcia E, Lara Fernandez A, Benavente-Lopez S, Raya Platero A, Barberan Navalon M, Sanchez-Alonso S, Vazquez-Bourgon J, Pappa S, Garcia-Carmona JA. Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y). Front Psychiatry. 2025 Mar 4;16:1540213. doi: 10.3389/fpsyt.2025.1540213. eCollection 2025. PubMed PMID: 40104335; PubMed Central PMCID: PMC11913845.
AÑO: 2025; IF: 3.8
|
40104335
|
Garcia-Carmona JA, Conesa-Garcia E, Vidal-Mena D, Gonzalez-Morales M, Ramos-Arenas V, Sanchez-Vizcaino-Buendia C, Soria-Torrecillas JJ, Perez-Vicente JA, Garcia-de-Guadiana-Romualdo L. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke. Neurologia (Engl Ed). 2024 Jul-Aug;39(6):496-504. doi: 10.1016/j.nrleng.2021.09.016. PubMed PMID: 38901926.
AÑO: 2024; IF: 3.1
|
|
Garcia-Carmona JA, Pappa S. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal. Drug Healthc Patient Saf. 2023 Sep 12;15:113-123. doi: 10.2147/DHPS.S339170. eCollection 2023. PubMed PMID: 37720806; PubMed Central PMCID: PMC10504906.
AÑO: 2023; IF: 1.6
|
|
Garcia-Carmona JA, Garcia-Perez A, Isidro Garcia G, Forcen-Munoz LA, Ovejero Garcia S, Saez Povedano R, Gonzalez-Galdamez AL, Mata Iturralde L, Hernandez-Sanchez F, Ramirez Bonilla M, Fuentes-Perez P, Ovejas-Catalan C, Suarez-Pinilla P, Valdivia-Munoz F, Fernandez Abascal B, Omana Colmenares M, de Lourdes Martin-Perez A, Campos-Navarro MP, Baca-Garcia E, Benavente-Lopez S, Raya Platero A, Barberan Navalon M, Sanchez-Alonso S, Vazquez-Bourgon J, Pappa S. Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study. Ther Adv Psychopharmacol. 2023 Dec 26;13:20451253231220907. doi: 10.1177/20451253231220907. eCollection 2023. PubMed PMID: 38152569; PubMed Central PMCID: PMC10752040.
AÑO: 2023; IF: 3.4
|
|
Quesada Lopez M, Amaya Pascasio L, Blanco Madera S, Pagola J, Vidal de Francisco D, de Celis Ruiz E, Villegas Rodriguez I, Carneado-Ruiz J, Garcia-Carmona JA, Garcia Torrecillas JM, Lopez Ferreiro A, Elosua Bayes I, Rigual Bobillo RJ, Lopez Lopez MI, Esain Gonzalez I, Ortega Ortega MD, Blanco Ruiz M, Perez Ortega I, Lazaro Hernandez C, Fuentes Gimeno B, Arjona Padillo A, Martinez Sanchez P. External Validation of SAFE Score to Predict Atrial Fibrillation Diagnosis after Ischemic Stroke: A Retrospective Multicenter Study. Stroke Res Treat. 2023 Dec 7;2023:6655772. doi: 10.1155/2023/6655772. eCollection 2023. PubMed PMID: 38099264; PubMed Central PMCID: PMC10721350.
AÑO: 2023; IF: 1.5
|